AU1073001A - Method of identifying inhibitors of cdc25 - Google Patents

Method of identifying inhibitors of cdc25

Info

Publication number
AU1073001A
AU1073001A AU10730/01A AU1073001A AU1073001A AU 1073001 A AU1073001 A AU 1073001A AU 10730/01 A AU10730/01 A AU 10730/01A AU 1073001 A AU1073001 A AU 1073001A AU 1073001 A AU1073001 A AU 1073001A
Authority
AU
Australia
Prior art keywords
cdc25
identifying inhibitors
inhibitors
identifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10730/01A
Inventor
Jill Blanchard
Nicholas Bockovich
David Borhani
Deborah Choquette
Jon Come
Richard W. Dixon
Jens Eckstein
David Epstein
Taro Fujimori
Andreas Haupt
Mark Hediger
Arthur Kluge
Kollol Pal
Kurt Ritter
Simon Robinson
Johannes Rudolph
Neil R Taylor
Nigel Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of AU1073001A publication Critical patent/AU1073001A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/02Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/24Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3882Arylalkanephosphonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1021Tetrapeptides with the first amino acid being acidic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2299/00Coordinates from 3D structures of peptides, e.g. proteins or enzymes
AU10730/01A 1999-10-12 2000-10-04 Method of identifying inhibitors of cdc25 Abandoned AU1073001A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21932099P 1999-10-12 1999-10-12
US60219320 1999-10-12
PCT/US2000/027361 WO2001027077A2 (en) 1999-10-12 2000-10-04 Hydroxysulfonylalkylene-, phosphonoalkylene- or difluoro(phosphononon)methyl- substituted benzene, or benzofuran derivatives as non-peptidic cdc25 inhibitors

Publications (1)

Publication Number Publication Date
AU1073001A true AU1073001A (en) 2001-04-23

Family

ID=22818812

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10730/01A Abandoned AU1073001A (en) 1999-10-12 2000-10-04 Method of identifying inhibitors of cdc25

Country Status (2)

Country Link
AU (1) AU1073001A (en)
WO (1) WO2001027077A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2383603A1 (en) * 1999-08-31 2001-03-08 Neil R. Taylor Method of identifying inhibitors of cdc25
WO2002070680A1 (en) * 2001-03-01 2002-09-12 Basf Aktiengesellschaft Method of identifying inhibitors of cdc25
US7057052B2 (en) 2002-09-26 2006-06-06 Duke University Heterocyclic quinones as pharmaceutical agents
ES2382876T3 (en) 2005-05-31 2012-06-14 Pfizer, Inc. Aryloxy-N-bicyclomethyl-acetamide compounds substituted as VR1 antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177095A (en) * 1990-02-13 1993-01-05 Merck & Co., Inc. Triazole angiotensin II antagonists incorporating a substituted benzyl element
DE69105495T2 (en) * 1990-04-02 1995-04-06 Pfizer BENZYLPHOSPHONIC ACID TYROSINKINAS INHIBITORS.
CA2090283A1 (en) * 1992-02-28 1993-08-29 Nobuyuki Hamanaka Phenoxyacetic acid derivatives
ATE189217T1 (en) * 1993-03-19 2000-02-15 Merck & Co Inc PHENOXYPHENYLACETIC ACID DERIVATIVES
US5559135A (en) * 1994-09-14 1996-09-24 Merck & Co., Inc. Endothelin antagonists bearing pyridyl amides
US5700821A (en) * 1996-07-30 1997-12-23 University Of Pittsburgh Phosphatase inhibitors and methods of use thereof

Also Published As

Publication number Publication date
WO2001027077A2 (en) 2001-04-19
WO2001027077A3 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
AU4677199A (en) Multibinding inhibitors of topoisomerase
AU2001249981A1 (en) Method of payroll access
AU4429799A (en) Inhibitors of p38
PL343007A1 (en) Inhibitors of phospholipase enzymes
PL342995A1 (en) Inhibitors of phospholipase enzymes
AU8030598A (en) Indole compounds as cox-2 inhibitors
IL138387A0 (en) Enzyme inhibitors
AU5619400A (en) Statine-derived tetrapeptide inhibitors of beta-secretase
AU5599598A (en) Inhibitors of glycosyltransferases
AU4156200A (en) Method of receiving information
AU1771901A (en) Method for rapid and accurate identification of microorganisms
AU7125700A (en) Enzyme inhibitors
AU3235100A (en) Prothease inhibitors
AU2001287268A1 (en) Method of identifying inhibitors of tie-2
GB9924522D0 (en) Enzyme inhibitors
AU2001278135A1 (en) Method of identifying immunosuppressive agents
AU2373600A (en) Novel spla2 inhibitors
AU1073001A (en) Method of identifying inhibitors of cdc25
AU7127000A (en) Enzyme inhibitors
GB9816358D0 (en) Enzyme inhibitors
AU7127100A (en) Enzyme inhibitors
AU4021700A (en) Methods of use of beta1-integrin inhibitors
AU3721000A (en) Corrosion inhibitor and process
AU7732000A (en) Method of identifying pathogenic cryptococci
AU2001241889A1 (en) Method of identifying inhibitors of cdc25

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase